Oligohydramnios sequence (Potter syndrome) happens when low amniotic fluid during pregnancy triggers severe fetal health concerns. The condition is more likely later in pregnancy when fluid is very ...

Some babies never make it to birth. Some — and there is no easy way to say this — are born to die. During pregnancy, a woman’s body undergoes fundamental changes to accommodate the growth of a fetus.

SINGAPORE – In his 35 years as an obstetrician, Professor Arijit Biswas has delivered more than 14,000 babies, but the 69-year-old is not ready to hang up his scrubs or even slow down. In fact, when ...

For Hollee Harris, RN, working in health care felt like destiny. She started her professional career with University of Utah Health about two years ago. The registered nurse began in internal medicine ...

USA: In neonates with bilateral renal agenesis, prenatal serial amnioinfusions can mitigate neonatal lethal pulmonary hypoplasia, but infants face substantial morbidity independent of lung function, ...

Using the world’s tiniest needle with a diametre of only 0.3mm, doctors have to be careful in every movement. The small needle is absolutely safe to both fetus and mother but poses a challenge to ...

Fetal therapy is commonly performed worldwide. Several studies reported that amnioinfusion may change intrauterine pressure and alter maternal and infant circulation, and that it improves fetal blood ...

This is a prospective observational study involving 80 cases of oligohydramnios treated with transabdominal amnioinfusion guided by ultrasound, in the period between 2011 and 2016. The patients were ...

Many common care practices during labor, birth, and the immediate postpartum period impact the fetal to neonatal transition, including medication used during labor, suctioning protocols, strategies to ...

J. L. is a healthy, 20-year-old gravida 2 para 0010 at 41 and 0/7 weeks' gestation, based on the first day of her last menstrual period and first trimester ultrasound. She was admitted to the labor ...

Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for ...

Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for ...